ID IFNK_HUMAN Reviewed; 207 AA. AC Q9P0W0; Q5T166; DT 01-MAR-2005, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2000, sequence version 1. DT 25-NOV-2008, entry version 50. DE RecName: Full=Interferon kappa; DE Short=IFN-kappa; DE Flags: Precursor; GN Name=IFNK; ORFNames=UNQ6124/PRO20084; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Cao X., Zhang W.; RT "Novel human interferon."; RL Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], FUNCTION, INDUCTION, AND RP TISSUE SPECIFICITY. RX MEDLINE=21523923; PubMed=11514542; DOI=10.1074/jbc.M102502200; RA LaFleur D.W., Nardelli B., Tsareva T., Mather D., Feng P., Semenuk M., RA Taylor K., Buergin M., Chinchilla D., Roshke V., Chen G., Ruben S.M., RA Pitha P.M., Coleman T.A., Moore P.A.; RT "Interferon-kappa, a novel type I interferon expressed in human RT keratinocytes."; RL J. Biol. Chem. 276:39765-39771(2001). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX MEDLINE=22887296; PubMed=12975309; DOI=10.1101/gr.1293003; RA Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., RA Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., RA Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., RA Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., RA Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J., RA Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A., RA Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H., RA Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D., RA Wood W.I., Godowski P.J., Gray A.M.; RT "The secreted protein discovery initiative (SPDI), a large-scale RT effort to identify novel human secreted and transmembrane proteins: a RT bioinformatics assessment."; RL Genome Res. 13:2265-2270(2003). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT LYS-133. RX PubMed=15164053; DOI=10.1038/nature02465; RA Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., RA Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., RA Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., RA Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R., RA Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P., RA Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W., RA Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G., RA Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M., RA Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W., RA Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A., RA Frankland J.A., French L., Fricker D.G., Garner P., Garnett J., RA Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S., RA Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E., RA Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D., RA Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E., RA Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K., RA Kimberley A.M., King A., Knights A., Laird G.K., Langford C., RA Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., RA Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., RA McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J., RA Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R., RA Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M., RA Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M., RA Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A., RA Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P., RA Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W., RA Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M., RA Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., RA Rogers J., Dunham I.; RT "DNA sequence and analysis of human chromosome 9."; RL Nature 429:369-374(2004). RN [5] RP PROTEIN SEQUENCE OF 28-42. RX PubMed=15340161; DOI=10.1110/ps.04682504; RA Zhang Z., Henzel W.J.; RT "Signal peptide prediction based on analysis of experimentally RT verified cleavage sites."; RL Protein Sci. 13:2819-2824(2004). RN [6] RP FUNCTION, AND TISSUE SPECIFICITY. RX PubMed=12391192; RA Nardelli B., Zaritskaya L., Semenuk M., Cho Y.H., LaFleur D.W., RA Shah D., Ullrich S., Girolomoni G., Albanesi C., Moore P.A.; RT "Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine RT production by cells of the innate immune system."; RL J. Immunol. 169:4822-4830(2002). CC -!- FUNCTION: May play a role in the regulation of immune cell CC function. Cytokine that imparts cellular protection against viral CC infection in a species-specific manner. Activates the interferon- CC stimulated response element signaling pathway. It is able to CC directly modulate cytokine release from monocytes and dendritic CC cells. Binds heparin. CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- TISSUE SPECIFICITY: Expressed in keratinocytes, monocytes and in CC resting dendritic cells. CC -!- INDUCTION: By viral infection, upon exposure to double-stranded CC RNA, or upon treatment with either interferon-gamma or interferon- CC beta. CC -!- SIMILARITY: Belongs to the alpha/beta interferon family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF146759; AAF67468.1; -; mRNA. DR EMBL; AF315688; AAK01623.1; -; mRNA. DR EMBL; AF384048; AAK63835.1; -; Genomic_DNA. DR EMBL; AY358855; AAQ89214.1; -; mRNA. DR EMBL; AL451123; CAI13042.1; -; Genomic_DNA. DR RefSeq; NP_064509.2; -. DR UniGene; Hs.591083; -. DR HSSP; P56828; 1B5L. DR PhosphoSite; Q9P0W0; -. DR Ensembl; ENSG00000147896; Homo sapiens. DR GeneID; 56832; -. DR KEGG; hsa:56832; -. DR H-InvDB; HIX0034769; -. DR HGNC; HGNC:21714; IFNK. DR PharmGKB; PA134970126; -. DR HOGENOM; Q9P0W0; -. DR HOVERGEN; Q9P0W0; -. DR NextBio; 62232; -. DR ArrayExpress; Q9P0W0; -. DR CleanEx; HS_IFNK; -. DR GermOnline; ENSG00000147896; Homo sapiens. DR GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW. DR GO; GO:0005132; F:interferon-alpha/beta receptor binding; IDA:UniProtKB. DR GO; GO:0019221; P:cytokine and chemokine mediated signaling p...; IDA:UniProtKB. DR GO; GO:0030101; P:natural killer cell activation; NAS:UniProtKB. DR GO; GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB. DR GO; GO:0045089; P:positive regulation of innate immune response; TAS:UniProtKB. DR GO; GO:0045449; P:regulation of transcription; IDA:UniProtKB. DR GO; GO:0009615; P:response to virus; IEP:UniProtKB. DR InterPro; IPR012351; 4_helix_cytokine_core. DR InterPro; IPR000471; Interferon_abd. DR Gene3D; G3DSA:1.20.1250.10; 4_helix_cytokine_core; 1. DR PANTHER; PTHR11691; Interferon_abd; 1. DR Pfam; PF00143; Interferon; 1. DR PRINTS; PR00266; INTERFERONAB. DR ProDom; PD000550; Interferon_abd; 1. DR SMART; SM00076; IFabd; 1. DR PROSITE; PS00252; INTERFERON_A_B_D; 1. PE 1: Evidence at protein level; KW Antiviral defense; Coiled coil; Cytokine; Direct protein sequencing; KW Polymorphism; Secreted; Signal. FT SIGNAL 1 27 FT CHAIN 28 207 Interferon kappa. FT /FTId=PRO_0000016410. FT COILED 118 148 Potential. FT DISULFID 30 128 By similarity. FT DISULFID 59 181 By similarity. FT VARIANT 97 97 I -> N (in dbSNP:rs34933275). FT /FTId=VAR_032710. FT VARIANT 133 133 E -> K (in dbSNP:rs700785). FT /FTId=VAR_021303. SQ SEQUENCE 207 AA; 25219 MW; 49CF410ECE52B597 CRC64; MSTKPDMIQK CLWLEILMGI FIAGTLSLDC NLLNVHLRRV TWQNLRHLSS MSNSFPVECL RENIAFELPQ EFLQYTQPMK RDIKKAFYEM SLQAFNIFSQ HTFKYWKERH LKQIQIGLDQ QAEYLNQCLE EDENENEDMK EMKENEMKPS EARVPQLSSL ELRRYFHRID NFLKEKKYSD CAWEIVRVEI RRCLYYFYKF TALFRRK //